IPadOS

From WikiMD's WELLNESSPEDIA

iPadOS is an operating system developed by Apple Inc. specifically for the company's iPad line of tablet computers. It was first announced at the Apple Worldwide Developers Conference in June 2019 as a derivative of iOS, the operating system used in the iPhone.

History[edit]

The first version of iPadOS, iPadOS 13, was released on September 24, 2019. It introduced several features designed to take advantage of the larger screen space of the iPad, including a new home screen layout with a permanent widget view, enhanced multitasking capabilities, and the ability to open multiple windows of the same app.

Features[edit]

iPadOS includes a number of features that differentiate it from iOS, including:

  • Split View and Slide Over: These multitasking features allow users to use two apps at the same time or quickly switch between apps.
  • Apple Pencil support: iPadOS includes a number of features designed to enhance the use of the Apple Pencil, including improved latency and new markup capabilities.
  • Safari: The version of Safari included in iPadOS is a desktop-class browser, meaning it automatically presents the desktop version of websites and includes features like a download manager and enhanced tab management.
  • Files app: The Files app in iPadOS provides a more robust file management system than in iOS, including support for external storage devices and file servers.

Versions[edit]

Since its initial release, Apple has regularly updated iPadOS to add new features and fix bugs. The most recent version, iPadOS 15, was released in September 2021 and introduced features like a redesigned multitasking interface, the ability to place widgets anywhere on the home screen, and the new Focus mode.

Reception[edit]

Since its release, iPadOS has been generally well received by critics and users. Many have praised its enhanced multitasking capabilities and the addition of a more robust file management system, although some have criticized its learning curve and occasional bugs.

See also[edit]





This tablet operating system related article is a stub.

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.